• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CYP1B1-RMDN2 阿尔茨海默病脑tau PET 内表型基因座的鉴定。

CYP1B1-RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PET.

机构信息

Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, USA.

Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, USA.

出版信息

Nat Commun. 2024 Sep 20;15(1):8251. doi: 10.1038/s41467-024-52298-2.

DOI:10.1038/s41467-024-52298-2
PMID:39304655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11415491/
Abstract

Determining the genetic architecture of Alzheimer's disease pathologies can enhance mechanistic understanding and inform precision medicine strategies. Here, we perform a genome-wide association study of cortical tau quantified by positron emission tomography in 3046 participants from 12 independent studies. The CYP1B1-RMDN2 locus is associated with tau deposition. The most significant signal is at rs2113389, explaining 4.3% of the variation in cortical tau, while APOE4 rs429358 accounts for 3.6%. rs2113389 is associated with higher tau and faster cognitive decline. Additive effects, but no interactions, are observed between rs2113389 and diagnosis, APOE4, and amyloid beta positivity. CYP1B1 expression is upregulated in AD. rs2113389 is associated with higher CYP1B1 expression and methylation levels. Mouse model studies provide additional functional evidence for a relationship between CYP1B1 and tau deposition but not amyloid beta. These results provide insight into the genetic basis of cerebral tau deposition and support novel pathways for therapeutic development in AD.

摘要

确定阿尔茨海默病病理的遗传结构可以增强对发病机制的理解,并为精准医疗策略提供信息。在这里,我们对来自 12 项独立研究的 3046 名参与者的皮质 Tau 通过正电子发射断层扫描进行了全基因组关联研究。CYP1B1-RMDN2 基因座与 Tau 沉积有关。最显著的信号位于 rs2113389,可解释皮质 Tau 变异的 4.3%,而 APOE4 rs429358 占 3.6%。rs2113389 与更高的 Tau 水平和更快的认知能力下降有关。在 rs2113389 与诊断、APOE4 和淀粉样蛋白β阳性之间观察到了累加效应,但没有相互作用。CYP1B1 的表达在 AD 中上调。rs2113389 与 CYP1B1 的更高表达和更高的甲基化水平有关。小鼠模型研究为 CYP1B1 与 Tau 沉积而不是淀粉样蛋白β之间的关系提供了额外的功能证据。这些结果深入了解了脑 Tau 沉积的遗传基础,并为 AD 的治疗开发提供了新的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d2/11415491/b63979a7c156/41467_2024_52298_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d2/11415491/ed6687fd7a55/41467_2024_52298_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d2/11415491/bca406f00c47/41467_2024_52298_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d2/11415491/e9bc621116d9/41467_2024_52298_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d2/11415491/caf185f60ba5/41467_2024_52298_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d2/11415491/b63979a7c156/41467_2024_52298_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d2/11415491/ed6687fd7a55/41467_2024_52298_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d2/11415491/bca406f00c47/41467_2024_52298_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d2/11415491/e9bc621116d9/41467_2024_52298_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d2/11415491/caf185f60ba5/41467_2024_52298_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d2/11415491/b63979a7c156/41467_2024_52298_Fig5_HTML.jpg

相似文献

1
CYP1B1-RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PET.CYP1B1-RMDN2 阿尔茨海默病脑tau PET 内表型基因座的鉴定。
Nat Commun. 2024 Sep 20;15(1):8251. doi: 10.1038/s41467-024-52298-2.
2
Novel Alzheimer's disease locus identified by genome-wide association analysis of cerebral tau deposition on PET.通过对PET脑tau蛋白沉积进行全基因组关联分析确定的新型阿尔茨海默病基因座。
medRxiv. 2023 Mar 22:2023.02.27.23286048. doi: 10.1101/2023.02.27.23286048.
3
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta.载脂蛋白E4(APOE4)对可溶性和不溶性tau蛋白病理的影响主要受β-淀粉样蛋白的影响。
Brain. 2025 Jan 16. doi: 10.1093/brain/awaf016.
4
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study.淀粉样蛋白 PET 和 tau-PET 评估唐氏综合征患者症状性阿尔茨海默病的时间轴:一项纵向队列研究。
Lancet Neurol. 2024 Dec;23(12):1214-1224. doi: 10.1016/S1474-4422(24)00426-5.
5
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者 Tau 蛋白扩散的比较:一项横断面研究。
Lancet Neurol. 2024 May;23(5):500-510. doi: 10.1016/S1474-4422(24)00084-X.
6
Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease.皮质 Tau 正电子发射断层扫描模式在临床前阿尔茨海默病患者中的差异。
JAMA Neurol. 2022 Jun 1;79(6):592-603. doi: 10.1001/jamaneurol.2022.0676.
7
Longitudinal Evolution of Financial Capacity and Cerebral Tau and Amyloid Burden in Older Adults with Normal Cognition or Mild Cognitive Impairment.认知正常或轻度认知障碍老年人的财务能力和大脑 Tau 与淀粉样蛋白负担的纵向演变。
J Prev Alzheimers Dis. 2024;11(4):966-974. doi: 10.14283/jpad.2023.121.
8
Association of Superficial White Matter Microstructure With Cortical Pathology Deposition Across Early Stages of the AD Continuum.AD连续体早期阶段浅表白质微结构与皮质病理沉积的关联
Neurology. 2025 Jul 22;105(2):e213666. doi: 10.1212/WNL.0000000000213666. Epub 2025 Jun 19.
9
Associations Between Self and Study Partner Report of Cognitive Decline With Regional Tau in a Multicohort Study.多队列研究中自我和学习伙伴报告的认知能力下降与区域 tau 之间的关联。
Neurology. 2024 Jun 25;102(12):e209447. doi: 10.1212/WNL.0000000000209447. Epub 2024 May 29.
10
Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and Genotype in Alzheimer Disease.阿尔茨海默病中认知变化的时间进程和严重程度与β淀粉样蛋白(Aβ)阳性及基因型的关系
Neurology. 2025 Jul 22;105(2):e213853. doi: 10.1212/WNL.0000000000213853. Epub 2025 Jun 27.

引用本文的文献

1
The Genetics of Amyloid Deposition: A Systematic Review of Genome-Wide Association Studies Using Amyloid PET Imaging in Alzheimer's Disease.淀粉样蛋白沉积的遗传学:使用淀粉样蛋白PET成像对阿尔茨海默病进行全基因组关联研究的系统综述。
J Imaging. 2025 Aug 19;11(8):280. doi: 10.3390/jimaging11080280.
2
Genome-wide association of tau neuroimaging and plasma biomarkers in adults with Down syndrome.唐氏综合征成人中tau神经影像学与血浆生物标志物的全基因组关联研究。
Alzheimers Dement. 2025 Jul;21(7):e70398. doi: 10.1002/alz.70398.
3
Cross-ancestry genome-wide association study identifies implications of SORL1 in cerebral beta-amyloid deposition.

本文引用的文献

1
Cell subtype-specific effects of genetic variation in the Alzheimer's disease brain.阿尔茨海默病大脑中遗传变异的细胞亚型特异性效应。
Nat Genet. 2024 Apr;56(4):605-614. doi: 10.1038/s41588-024-01685-y. Epub 2024 Mar 21.
2
Genome-wide association study of brain tau deposition as measured by F-flortaucipir positron emission tomography imaging.全基因组关联研究脑 Tau 沉积的 F-氟替卡滨正电子发射断层扫描成像测量。
Neurobiol Aging. 2022 Dec;120:128-136. doi: 10.1016/j.neurobiolaging.2022.09.002. Epub 2022 Sep 10.
3
Integrative Co-methylation Network Analysis Identifies Novel DNA Methylation Signatures and Their Target Genes in Alzheimer's Disease.
跨血统全基因组关联研究确定了SORL1在脑β-淀粉样蛋白沉积中的作用。
Nat Commun. 2025 Apr 2;16(1):3150. doi: 10.1038/s41467-025-57751-4.
4
The Role of Genetic, Environmental, and Dietary Factors in Alzheimer's Disease: A Narrative Review.遗传、环境和饮食因素在阿尔茨海默病中的作用:一项叙述性综述
Int J Mol Sci. 2025 Jan 30;26(3):1222. doi: 10.3390/ijms26031222.
整合共甲基化网络分析鉴定阿尔茨海默病中新型 DNA 甲基化特征及其靶基因。
Biol Psychiatry. 2023 May 1;93(9):842-851. doi: 10.1016/j.biopsych.2022.06.020. Epub 2022 Jun 24.
4
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.全基因组荟萃分析阿尔茨海默病脑脊液生物标志物。
Acta Neuropathol. 2022 Nov;144(5):821-842. doi: 10.1007/s00401-022-02454-z. Epub 2022 Sep 6.
5
Cytochrome P450 1B1: role in health and disease and effect of nutrition on its expression.细胞色素P450 1B1:在健康与疾病中的作用以及营养对其表达的影响
RSC Adv. 2019 Jul 4;9(36):21050-21062. doi: 10.1039/c9ra03674a. eCollection 2019 Jul 1.
6
Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer's disease.tau 多基因风险评分:阿尔茨海默病预后咨询的一种具有成本效益的辅助手段。
Acta Neuropathol. 2022 May;143(5):571-583. doi: 10.1007/s00401-022-02419-2. Epub 2022 Apr 12.
7
New insights into the genetic etiology of Alzheimer's disease and related dementias.阿尔茨海默病及相关痴呆症的遗传学病因新见解。
Nat Genet. 2022 Apr;54(4):412-436. doi: 10.1038/s41588-022-01024-z. Epub 2022 Apr 4.
8
PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer's disease.PLCG2 与炎症反应有关,并且由阿尔茨海默病中的淀粉样斑块诱导。
Genome Med. 2022 Feb 18;14(1):17. doi: 10.1186/s13073-022-01022-0.
9
Association of peripheral blood DNA methylation level with Alzheimer's disease progression.外周血 DNA 甲基化水平与阿尔茨海默病进展的关联。
Clin Epigenetics. 2021 Oct 15;13(1):191. doi: 10.1186/s13148-021-01179-2.
10
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.一项针对 1126563 人的全基因组关联研究确定了阿尔茨海默病的新风险基因座。
Nat Genet. 2021 Sep;53(9):1276-1282. doi: 10.1038/s41588-021-00921-z. Epub 2021 Sep 7.